A,B) Incidence of multiple myeloma in China in 2016. Standardized... | Download Scientific Diagram
A phase I study of anti‐BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia - Li - 2021 - Clinical and Translational Medicine - Wiley Online Library
ICD-10 Coordination and Maintenance Committee Meeting ICD-10-PCS Therapeutic Agent Topics
ICD-10 Code for Multiple myeloma- C90.0- Codify by AAPC
Cardiac amyloidosis: An underdiagnosed/underappreciated disease - ScienceDirect
DARZALEX® (daratumumab) ICD-10 Codes | Janssen CarePath for Healthcare Professionals
Immune marker changes and risk of multiple myeloma: a nested case-control study using repeated pre-diagnostic blood samples | Haematologica
Clinical outcomes of bortezomib-based therapy in Taiwanese patients with multiple myeloma: A nationwide population-based study and a single-institute analysis | PLOS ONE
Cureus | Rhabdomyolysis and Acute Renal Dysfunction as Initial Manifestations of Monoclonal Gammopathy of Renal Significance | Article
Monoclonal gammopathy of undetermined significance is associated with prostate cancer in a population-based cohort study | Scientific Reports
Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients - Frontiers
Risk factors for infections in newly diagnosed Multiple Myeloma patients: A Danish retrospective nationwide cohort study - Sørrig - 2019 - European Journal of Haematology - Wiley Online Library